Inhibition of herpes simplex virus type 1 entry by chloride channel inhibitors tamoxifen and NPPB

Biochemical and Biophysical Research Communications

Volumn 446, Issue 4, 2014, Pages 990-996

  Zheng, Kai ^a   Chen, Maoyun ^a   Xiang, Yangfei ^a   Ma, Kaiqi ^a   Jin, Fujun ^a   Wang, Xiao ^b   Wang, Xiaoyan ^a   Wang, Shaoxiang ^a   Wang, Yifei ^a  

^a JINAN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Chloride channels; Entry; FDA; HSV; NPPB; Tamoxifen

Indexed keywords

5-NITRO-2-(3-PHENY L-PROPYLAMINO) BENZOIC ACID; ACV; ACYCLOVIR; CHLORIDE CHANNELS; CHOLERATOXIN BETA SUBUNIT; CTXB; ENTRY; ER; ESTROGEN RECEPTOR; FDA; FOOD AND DRUG ADMINISTRATION; HCV; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HSV; MQAE; N-(ETHOXYCARBONYLMETHYL)-6-METHOXYQUINOLINIUM BROMIDE; NPPB; TAMOXIFEN;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; CHLORIDE CHANNELS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; NITROBENZOATES; TAMOXIFEN; VERO CELLS; VIRUS INTERNALIZATION;

EID: 84899483971     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.03.050     Document Type: Article

References (32)

1. K.L. Tyler Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's Herpes 11 2004 57A 64A
2. S.S. Wilson, E. Fakioglu, and B.C. Herold Novel approaches in fighting herpes simplex virus infections Expert. Rev. Anti. Infect ther. 7 2009 559 568
3. L.C. Norkin Virology: Molecular Biology and Pathogenesis 2010 American Society for Microbiology Press USA
4. H.J. Schaeffer, L. Beauchamp, P. de Miranda, G.B. Elion, D.J. Bauer, and P. Collins 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group Nature 272 1978 583 585
5. J.A. Fyfe, P.M. Keller, P.A. Furman, R.L. Miller, and G.B. Elion Thymidine kinase form herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl) guanine J. Biol. Chem. 253 1978 8721 8727
6. J. Piret, and G. Boivin Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management Antimicrob. Agents Chemother. 55 2011 459 472
7. J.P. Moore, and R.W. Doms The entry of entry inhibitors: a fusion of science and medicine Proc. Natl. Acad. Sci. USA 100 2003 10598 10602
8. T. Gianni, G. Campadelli-Fiume, and L. Menotti Entry of herpes simplex virus mediated by chimeric forms of nectin1 retargeted to endosomes or to lipid rafts occurs through acidic endosomes J. Virol. 78 2004 12268 12276
9. R.S. Milne, A.V. Nicola, J.C. Whitbeck, R.J. Eisenberg, and G.H. Cohen Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1 J. Virol. 79 2005 6655 6663
10. A.V. Nicola, A.M. McEvoy, and S.E. Straus Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells J. Virol. 77 2003 5324 5332
11. J.A. Schwartz, E.K. Lium, and S.J. Silverstein Herpes simplex virus type 1 entry is inhibited by the cobalt chelate complex CTC-96 J. Virol. 75 2001 4117 4128
12. D. Baram-Pinto, S. Shukla, A. Gedanken, and R. Sarid Inhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles Small 6 2010 1044 1050
13. J. Rajcani, and V. Durmanova Developments in herpes simplex virus vaccines: old problems and new challenges Folia Microbiol. (Praha) 51 2006 67 85
14. M.G. Zhong, Y.F. Xiang, X.X. Qiu, Z. Liu, K. Kitazato, and Y.F. Wang Natural products as a source of anti-herpes simplex virus agents RSC Adv. 3 2013 313 328
15. W.A. Catterall, S. Cestèle, V. Yarov-Yarovoy, F.H. Yu, K. Konoki, and T. Scheuer Voltage-gated ion channels and gating modifier toxins Toxicon 49 2007 124 141
16. A.S. Verkman, and L.J.V. Galietta Chloride channels as drug targets Nat. Rev. 8 2009 153 171
17. J.W. Phillis, D. Song, and M.H. O'Regan Tamoxifen, a chloride channel blocker, reduces glutamate and aspartate release from the ischemic cerebral cortex Brain Res. 780 1998 352 355
18. J.J. Zhang, T.J. Jacob, M.A. Valverde, S.P. Hardy, G.M. Mintenig, F.V. Sepúlveda, D.R. Gill, S.C. Hyde, A.E. Trrezise, and C.F. Higgins Tamoxifen blocks chloride channels. A possible mechanism for cataract formation J. Clin. Invest. 94 1994 1690 1697
19. V.C. Jordan Fourteenth Gaddum memorial lecture. A current view of tamoxifen for the treatment and prevention of breast cancer Br. J. Pharmacol. 110 1993 507 517
20. Y. Wang, Q. Wang, Q. Zhu, R. Zhou, J. Liu, and T. Peng Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children J. Clin. Virol. 52 2011 107 112
21. Y. Xiang, K. Zheng, H. Ju, S. Wang, Y. Pei, W. Ding, Z. Chen, Q. Wang, X. Qiu, M. Zhong, F. Zeng, Z. Ren, C. Qian, G. Liu, K. Kitazato, and Y. Wang Cofilin 1-mediated biphasic F-actin dynamics of neuronal cells affect herpes simplex virus 1 infection and replication J. Virol. 86 2012 8440 8451
22. K. Zheng, Y.F. Xiang, X. Wang, Q. Wang, M. Zhong, S. Wang, X. Wang, J. Fan, K. Kitazato, and Y.F. Wang Epidermal growth factor receptor-PI3K signaling controls cofilin activity to facilitate herpes simplex virus 1 entry into neuronal cells mBio 5 2014 e00985-13
23. L.M. Johansen, J.M. Brannan, S.E. Delos, C.J. Shoemaker, A. Stossel, C. Lear, B.G. Hoffstrom, L. Evans DeWald, K.L. Schornberg, C. Scully, J. Lehár, L.E. Hensley, J.M. White, and G.G. Olinger FDA-approved selective estrogen receptor modulators inhibits ebola virus infection Sci. Transl. Med. 190 2013 190ra79
24. L. Pelkmans, J. Kartenbeck, and A. Helenius Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER Nat. Cell Biol. 3 2001 473 483
25. T. Gianni, and G. Campadelli-Fiume αVβ3-integrin relocalizes nectin 1 and routes herpes simplex virus to lipid rafts J. Virol. 86 2012 2850 2855
26. N. Cheshenko, B. Del Rosario, C. Woda, D. Marcellino, L.M. Satlin, and B.C. Herold Herpes simplex virus triggers activation of calcium-signaling pathways J. Cell Biol. 163 2003 283 293
27. N. Cheshenko, W. Liu, L.M. Satlin, and B.C. Herold Multiple receptor interactions trigger release of membrane and intracellular calcium stores critical for herpes simplex virus entry Mol. Biol. Cell 18 2007 3119 3130
28. R. Altmeyer Virus attachment and entry offer numerous targets for antiviral therapy Curr. Pharm. Des. 10 2004 3701 3712
29. Z. Sasvari, N. Kovalev, and P.D. Nagy The GEF1 proton-chloride exchanger affects tombusvirus replication via regulation of copper metabolism in yeast J. Virol. 87 2013 1800 1810
30. K. Watashi, D. Inoue, M. Hijikata, K. Goto, H.H. Aly, and K. Shimotono Anti-hepatitis C virus activity of tamoxifen reveals the functional association of estrogen receptor with viral RNA polymerase NS5B J. Biol. Chem. 282 2007 32765 32772
31. Y. Murakami, M. Fukasawa, Y. Kaneko, T. Suzuki, T. Wakita, and H. Eukazawa Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle Microbes. Infect. 15 2013 45 55
32. D.J. Lindner, V. Kolla, D.V. Kalvakolanu, and E.C. Borden Tamoxifen enhanced interferon-regulated gene expression in breast cancer cells Mol. Cell. Biochem. 167 1997 169 177